XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.3
Derivative Instruments
 9 Months Ended
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Note 12 – Derivative Instruments
The Company uses derivative instruments, specifically, forward foreign exchange contracts, to manage the risk associated with the volatility of future cash flows. The forward foreign exchange contracts are used to mitigate the impact of exchange rate fluctuations on certain forecasted inventory purchases and are designated as cash flow hedges.
The notional amounts of the Company’s outstanding derivative instruments as of September 30, 2025 and December 31, 2024 were as follows:
September 30, 2025December 31, 2024
Derivative instruments designated as accounting hedges:
Foreign exchange contracts$109,428 $90,031 
The fair value of the Company’s outstanding derivative instruments as of September 30, 2025 and December 31, 2024 were as follows:
Balance Sheet ClassificationSeptember 30, 2025December 31, 2024
Assets:
Forward contractsOther current assets$352 $2,175 
Liabilities:
Forward contractsOther current liabilities$3,062 $816 
The following table presents the pretax impact of gains/(loss) from the Company's designated derivative instruments on its Condensed Consolidated Financial Statements for the periods ended September 30, 2025 and September 30, 2024:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Cash flow hedges:
Foreign exchange contracts$1,161 $(1,039)$(4,000)$482 
As of September 30, 2025, the current maturity dates of the Company’s derivative instruments range from July 2025 to September 2026.
For the periods ended September 30, 2025 and 2024, the Company's hedging activities were deemed effective, with no ineffectiveness recognized in the Condensed Consolidated Statements of Operations. Gains and losses from these hedging activities are recorded in cost of sales in the Condensed Consolidated Statements of Operations.
In the second quarter of 2025, the Company settled certain foreign exchange forward contracts that were entered into to hedge foreign exchange rate risk surrounding a portion of the purchase price in connection with the Kurt Geiger acquisition. The settlement resulted in a gain of $9,252, which was recorded as gain on derivative in the Company's Condensed Consolidated Statements of Operations for the nine months ended September 30, 2025.